Hakon Blomstrand

Clinical characteristics and blood/serum bound prognostic biomarkers in advanced pancreatic cancer treated with gemcitabine and nab-paclitaxel

M. Fredrikson, N. Elander, H. Gréen, 2019, BMC cancer.

Real-World Evidence on Palliative Gemcitabine and Oxaliplatin (GemOx) Combination Chemotherapy in Advanced Biliary Tract Cancer

N. Elander, Hakon Blomstrand, Hanna Lagenfelt, 2021, Cancers.

Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer

N. Elander, A. Batra, W. Cheung, 2021, World journal of clinical oncology.

Complete Radiologic Response of Metastatic Pancreatic Ductal Adenocarcinoma to Microwave Ablation Combined with Second-Line Palliative Chemotherapy

B. Björnsson, P. Sandström, Karin Adolfsson, 2020, Case reports in gastrointestinal medicine.

Real World Evidence on Second-Line Palliative Chemotherapy in Advanced Pancreatic Cancer

M. Fredrikson, N. Elander, E. Åvall-Lundqvist, 2020, Frontiers in Oncology.

Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer

N. Elander, H. Gréen, C. Bratthäll, 2019, BMC Cancer.

Impact of resection margins and para-aortic lymph node metastases on recurrence patterns and prognosis in resectable pancreatic cancer - a long-term population-based cohort study.

N. Elander, H. Olsson, B. Björnsson, 2023, HPB : the official journal of the International Hepato Pancreato Biliary Association.

World Journal of Clinical Oncology

A. Batra, Hakon Blomstrand, Winson Y. Cheung, 2021 .